COVID-19 drug development based on boosting immunity
Posted: 31 December 2020 | Baidyanath Dash (G3 Systems) | No comments yet
Baidyanath Dash explains the two requirements for COVID-19 drug development: killing the virus and boosting immunity.
Click here to read the article.
With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit:
Related topics
Disease research, Drug Development, Drug Targets, Research & Development, Targets
Related conditions
Covid-19


